W ouldn't it be great to sail through the rest of winter with soft skin? For the 78 percent of us bothered by itchy or sore ...

Johnson & Johnson , fresh off a $14.6 billion deal to buy neurological drugmaker Intra-Cellular , reported fourth-quarter ...

That’s the message from Cathy O’Brien, CEO of Naturopathica, the botanical skincare brand with five “healing centers” across ...

Investing.com - Johnson & Johnson (NYSE:JNJ) posted fourth-quarter adjusted earnings and sales that topped analysts' estimates, as the pharmaceutical firm was boosted by demand for its cancer ...

Icelandic drug discovery and development company Arctic Therapeutics (ATx) today announced the successful closing of a €26.5 million oversubscribed Series A financing from a broad syndicate of ...

.Semaglutide: Novo Nordisk Semaglutide is a long-acting oral GLP-1 analogue being developed and investigated by Novo Nordisk. The drug is currently being evaluated under Phase III clinical trial for ...

Promising review: "I bought this to try because I heard it was as good as (if not better than) Olaplex. I paid for Olaplex at ...

Whatever form it takes, successful treatment reverses the changes in brain circuitry that make substance use hard to control. Yet many factors other than biology must be addressed for treatment to ...

Oil India Ltd. key Products/Revenue Segments include Oil Crude, Gas Natural, Income From Transportation Services, Renewable Energy System, Condensate for the year ending 31-Mar-2024.For the quarter ...